Inventor · disambiguated record
Claudio Edmundo Chuaqui
Also filed as: CHUAQUI CLAUDIO · CHUAQUI CLAUDIO EDMUNDO
11 granted patents·9 pending applications·25 citations·filing 2009–2024
87Inventor score
Files withSYROS PHARMACEUTICALS INC10ASTRAZENECA AB6DIZAL JIANGSU PHARMACEUTICAL CO LTD3CHUAQUI CLAUDIO EDMUNDO1
Top patents by PatentIndex Score
20 records- 0194US10738067B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2020·Granted Aug 11, 2020·5 cites·30 claims
- 0288US9714236B2Compounds and methods for inhibiting JAKASTRAZENECA AB·Filed 2016·Granted Jul 25, 2017·6 cites·5 claims
- 0386US11247983B2Compounds and methods for inhibiting JAKDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2020·Granted Feb 15, 2022·2 cites·19 claims
- 0486US10167276B2Compounds and methods for inhibiting JAKDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2017·Granted Jan 1, 2019·5 cites·5 claims
- 0584US10654835B2Compounds and methods for inhibiting JAKDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2018·Granted May 19, 2020·3 cites·22 claims
- 0684US2024425476A12-(2,4,5-substituted-anilino)pyrimidine compoundsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0783US12240869B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2019·Granted Mar 4, 2025·1 cites·27 claims
- 0882US11311542B2Inhibitors of cyclin dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2019·Granted Apr 26, 2022·3 cites·20 claims
- 0982US2024182441A12-(2,4,5-substituted-anilino)pyrimidine compoundsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 1072US2024360165A1Inhibitors of cyclin dependent kinase 7 (cdk7)SYROS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1170US11524951B22-(2,4,5-substituted-anilino)pyrimidine compoundsASTRAZENECA AB·Filed 2020·Granted Dec 13, 2022·0 cites·8 claims
- 1269US10858336B22-(2,4,5-substituted-anilino)pyrimidine compoundsASTRAZENECA AB·Filed 2019·Granted Dec 8, 2020·0 cites·7 claims
- 1362US2022305014A1Inhibitors of cyclin dependent kinase 7 (cdk7)SYROS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1461US2023062491A1Inhibitors of cyclin dependent kinase 7 (cdk7)SYROS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1557US2021147431A1Pyrrolotriazine compounds and methods of inhibiting tam kinasesSYROS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1653US2011201628A1Heterocyclic jak kinase inhibitorsCHUAQUI CLAUDIO EDMUNDO·Filed 2009·Application pending·0 cites
- 1752US11040981B2Pyrrolotriazine compounds and methods of inhibiting TAM kinasesSYROS PHARMACEUTICALS INC·Filed 2018·Granted Jun 22, 2021·0 cites·28 claims
- 1851US2011183954A1Tricyclic 2,4-diamino-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disordersASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1946US11918592B2Inhibitors of cyclin dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2019·Granted Mar 5, 2024·0 cites·26 claims
- 2044US2020071326A1Tam kinase inhibitorsSYROS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Claudio Edmundo Chuaqui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →